Back

11 August 2024

Olympic Games Paris 2024 – the ITA asserts an apparent anti-doping rule violation against Congolese athlete Dominique Lasconi Mulamba

The International Testing Agency (ITA) reports that a sample collected from athlete Lasconi Mulamba from the Democratic Republic of Congo (Athletics - 100m sprint) has returned an Adverse Analytical Finding for the non-specified prohibited substance stanozolol metabolite (classified as S1. Anabolic Androgenic Steroid according to the Prohibited List of the World Anti-Doping Agency (WADA)).

An Adverse Analytical Finding (AAF) is a report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a Sample the presence of a Prohibited Substance or its Metabolites or Markers or evidence of the Use of a Prohibited Method.

Share

Cookie Policy & Privacy Notice

We use cookies on our website to personalize content, to analyze traffic on our website to provide social media features. We share your data with our analytics partners and social media content providers. Find out more

The privacy policy can be accessed here

Your current state: Consent rejected.


Accept Reject Read More